BR2 - Belgian Reactor 2

The BR2 reactor was first operated in Januari 1963. This Materials Testing Reactor is SCK•CEN's most important nuclear facility. It was operated during the past forty years within the framework of many international programmes concerning the development of structural materials and nuclear fuels for various types of nuclear fission reactors as well as for fusion reactor research.

BR2 reactor building
BR2 core

Research & Development

The qualities and particular features of the BR2 reactor also allowed experiments to be performed that were aimed at assessing and demonstrating the safety of nuclear cores.

Today, the reactor plays an essential role in the national and international programmes related to:

Production of radioisotopes and silicon

BR2 silicon

Besides its scientific R&D objectives, the BR2 reactor has a second mission: it plays an important role in the support of medicine, by the production of radioisotopes used for diagnostics, the fight against cancer and palliative care. Thus, the reactor is not only used fot scientific research within SCK•CEN's own programmes and for external clients; it is also used for the production of radio-elements and for the production of Neutron Transmutation Doped (NTD) silicon (Si).

BR2 is one of the best performing reactors in the world and it is becoming more important as the number of such research reactors is declining worldwide.

Technical specifications

BR2 cross section

The capabilities and the design of the BR2 are particularly well suited to R&D options, offering:

Two dedicated irradiation devices that are currently in operation for the irradiation testing of LWR fuels are:

To the top

Contact person(s)

Van Dyck Steven


© 2008-2012 SCK•CEN - http://www.sckcen.be/Our-Research/Research-facilities/BR2-Belgian-Reactor-2 - 2012-02-10